Literature DB >> 15831636

Atherosclerosis-like lesions of the aortic valve are common in adults of all ages: a necropsy study.

J Kuusisto1, K Räsänen, T Särkioja, E Alarakkola, V-M Kosma.   

Abstract

OBJECTIVE: To determine the presence and size of atherosclerosis-like lesions in aortic valves of unselected adults of all ages.
DESIGN: Necropsy study.
SETTING: Departments of Forensic Medicine and Pathology at the University of Oulu and the Oulu University Hospital in Finland.
SUBJECTS: 48 consecutive unselected adult subjects (15 subjects aged 20-40 years, 17 aged 41-60, and 16 aged >or= 61) undergoing necropsy. MAIN OUTCOME MEASURES: Detection of the presence of atherosclerosis-like lesions and mineralisation in aortic valves, and morphometrical measurement of the size of lesions.
RESULTS: None of the necropsy subjects had aortic stenosis and only two subjects had macroscopic calcification of the aortic valve. Of 48 subjects, however, 45 had an atherosclerosis-like subendothelial thickening above the elastic lamina on the aortic side of at least one of the valve leaflets. Of 15 young subjects aged 20-40 years, eight had a lesion in the right coronary cusp of the aortic valve and 12 had a lesion in at least one of the three aortic valve leaflets. Of 17 middle aged subjects, 16 had an early lesion in the right coronary cusp and all had a lesion in at least one of the valve leaflets. In the oldest age group, all 16 subjects had a lesion in every valve leaflet. The mean lesion area in the three valve leaflets varied from 0.1-0.2 mm(2) in young subjects, 0.5-0.8 mm(2) in middle aged, and 1.3-2.3 mm(2) in elderly subjects (p < 0.001). Microscopic calcification in the right coronary cusp of the aortic valve was observed in 12 of 17 middle aged and 14 of 16 elderly subjects but only in one young subject.
CONCLUSIONS: Atherosclerosis-like lesions in the aortic valve are prevalent in adults of all age groups, including young subjects aged 20-40 years, suggesting that the disease process leading to aortic stenosis is common, often beginning in early adulthood.

Entities:  

Mesh:

Year:  2005        PMID: 15831636      PMCID: PMC1768889          DOI: 10.1136/hrt.2004.036848

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  17 in total

1.  Why is there discordance between calcific aortic stenosis and coronary artery disease?

Authors:  C M Otto; K D O'Brien
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Aortic stenosis: a new face for an old disease.

Authors:  Joseph S Alpert
Journal:  Arch Intern Med       Date:  2003 Aug 11-25

Review 3.  Aortic stenosis: an atherosclerotic disease?

Authors:  A Wierzbicki; C Shetty
Journal:  J Heart Valve Dis       Date:  1999-07

4.  Osteopontin is expressed in human aortic valvular lesions.

Authors:  K D O'Brien; J Kuusisto; D D Reichenbach; M Ferguson; C Giachelli; C E Alpers; C M Otto
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

Review 5.  Coronary atherosclerosis. A multifactorial disease.

Authors:  J J Badimon; V Fuster; J H Chesebro; L Badimon
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

6.  Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis.

Authors:  K D O'Brien; D D Reichenbach; S M Marcovina; J Kuusisto; C E Alpers; C M Otto
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-04       Impact factor: 8.311

7.  Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves.

Authors:  M Olsson; C J Dalsgaard; A Haegerstrand; M Rosenqvist; L Rydén; J Nilsson
Journal:  J Am Coll Cardiol       Date:  1994-04       Impact factor: 24.094

8.  Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies.

Authors:  C M Otto; J Kuusisto; D D Reichenbach; A M Gown; K D O'Brien
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

9.  Association between apolipoprotein E alleles and calcific valvular heart disease.

Authors:  Gian M Novaro; Ravish Sachar; Gregory L Pearce; Dennis L Sprecher; Brian P Griffin
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

10.  Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma.

Authors:  Kevin D O'Brien; David M Shavelle; Michael T Caulfield; Thomas O McDonald; Katherine Olin-Lewis; Catherine M Otto; Jeffrey L Probstfield
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

View more
  12 in total

1.  Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins.

Authors:  D Skowasch; S Schrempf; C J Preusse; J A Likungu; A Welz; B Lüderitz; G Bauriedel
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  Sudden death due to pulmonary embolism from right atrial myxoma.

Authors:  T Fracasso; K Varchmin-Schultheiss
Journal:  Int J Legal Med       Date:  2009-01-06       Impact factor: 2.686

3.  Plasma lipids and risk of aortic valve stenosis: a Mendelian randomization study.

Authors:  Milad Nazarzadeh; Ana-Catarina Pinho-Gomes; Zeinab Bidel; Abbas Dehghan; Dexter Canoy; Abdelaali Hassaine; Jose Roberto Ayala Solares; Gholamreza Salimi-Khorshidi; George Davey Smith; Catherine M Otto; Kazem Rahimi
Journal:  Eur Heart J       Date:  2020-10-21       Impact factor: 29.983

4.  Pro-Inflammatory Serum Amyloid a Stimulates Renal Dysfunction and Enhances Atherosclerosis in Apo E-Deficient Mice.

Authors:  Antony Gao; Sameesh Gupta; Han Shi; Yuyang Liu; Angie L Schroder; Paul K Witting; Gulfam Ahmad
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

5.  Hemodynamic environments from opposing sides of human aortic valve leaflets evoke distinct endothelial phenotypes in vitro.

Authors:  Eli J Weinberg; Peter J Mack; Frederick J Schoen; Guillermo García-Cardeña; Mohammad R Kaazempur Mofrad
Journal:  Cardiovasc Eng       Date:  2010-03

6.  A computational model of aging and calcification in the aortic heart valve.

Authors:  Eli J Weinberg; Frederick J Schoen; Mohammad R K Mofrad
Journal:  PLoS One       Date:  2009-06-18       Impact factor: 3.240

7.  Carotenoids co-localize with hydroxyapatite, cholesterol, and other lipids in calcified stenotic aortic valves. Ex vivo Raman maps compared to histological patterns.

Authors:  A Bonetti; A Bonifacio; A Della Mora; U Livi; M Marchini; F Ortolani
Journal:  Eur J Histochem       Date:  2015-04-20       Impact factor: 3.188

8.  Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease Etiology.

Authors:  Ana M Porras; Dhanansayan Shanmuganayagam; Jennifer J Meudt; Christian G Krueger; Timothy A Hacker; Peter S Rahko; Jess D Reed; Kristyn S Masters
Journal:  J Am Heart Assoc       Date:  2015-10-27       Impact factor: 5.501

9.  Cholesterol induced heart valve inflammation and injury: efficacy of cholesterol lowering treatment.

Authors:  Layan A El-Khatib; Heather De Feijter-Rupp; Abed Janoudi; Levi Fry; Michael Kehdi; George S Abela
Journal:  Open Heart       Date:  2020-08

10.  Superimposed Tissue Formation in Human Aortic Valve Disease: Differences between Regurgitant and Stenotic Valves.

Authors:  Boudewijn P T Kruithof; Aniek L van Wijngaarden; Babak Mousavi Gourabi; Jesper Hjortnaes; Meindert Palmen; Nina Ajmone Marsan
Journal:  J Cardiovasc Dev Dis       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.